Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
04/08/2026
The trading volume of the Shanghai and Shenzhen stock markets exceeded 500 billion yuan, a decrease of 66.5 billion yuan compared to the same time yesterday.
Latest
2 m ago
Hong Kong Stock Movement | Sanhuan Group (06951.HK) rises over 5% again as MLCC giant continues to increase prices. The company has completed its first round of share repurchases and launched a second round of buybacks.
2 m ago
Hong Kong Stock Movement | Computation power is on the rise, with both PCB volume and price increasing. Chipbond Technology (09630.HK) rose over 14%, and Dazheng CNC (03200.HK) rose over 8%.
4 m ago
The PTA continuous main contract rose 2% during the day and is now priced at 5960.00 yuan.
6 m ago
*ST Zhongdi surged to the daily limit during trading. According to news, the companys actual controllers and related parties intend to provide a guarantee of 45 million yuan for subsidiaries including Guangxi Tianwei Electronics Co., Ltd.
6 m ago
Hkg Stock MovementKejia Pharmaceuticals-B (02171.HK) surged over 4% after CT0596 received IND approval from the National Medical Products Administration for the treatment of R/R MM patients.
See all latest